Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Blocking mTORC1 reduces skin tumor growth in mice.

New molecules can prevent cell death in hair follicles.

c-Kit is important for heart regeneration and cancer development.

Cancer prevention has advanced significantly, with some strategies proving successful.

The treatment was ineffective in humans.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Suppressing ODC activity reduces tumor growth in hair follicles.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

JAK inhibitors show promise in treating difficult skin diseases.

JAK inhibitors are effective for long-term management of alopecia areata.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

JAK inhibitors might help treat alopecia areata.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.